Effect of Clinical Study of Moringa oleifera on Body mass index, Low density lipoprotein and Triglyceride level in Patients on Tenofovir/lamivudine/efavirenz Combination Therapy

Document Type : Original Article

Authors

1 Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Gombe State University, Gombe State, Nigeria.

2 University college Hospital

Abstract

Background and aim: HIV/AIDS drugs usually have undesirable side effect. Moringa oleifera is a plant that has been uses for various beneficial purposes. The aim of this study is to investigate the potential benefits of Moringa oleifera on blood triglyceride and low density lipoprotein (LDL) levels in patient receiving tenofovir/lamivudine/efavirenz (TLE) combination therapy.
Methods: The protocol was designed as a Longitudinal Randomized Comparative Trial (LRCT) involving 140 HIV adult subjects (56  men and  84 women) who had already been on TLE (300/300/600mg) combination therapy for at least 6 months prior to the study. They were enrolled from a teaching hospital in Nigeria. M. oleifera capsules (200mg) were given to the subjects to be used from the first day as visit 0 until visit 1 (four weeks after) and 2 (12 weeks after). Blood samples of subjects were collected at visits 0, 1 and 2 and serum analyzed for triglyceride and LDL levels
 Results: There was a significant decrease in serum LDL level (p <0.01) at visit 1 compared to visit 0. There was also significant (p <0.01) improvement compared to visit 0 and visit 1. There was a significant decrease in blood triglyceride level (p <0.01) at visit 1 compared to visit 0 of TLE combination. At visit on day 2, there was a further significant decrease in triglyceride level compared to visit 0 Conclusion: M. oleifera may 
be useful in improving blood triglyceride and LDL levels of patients receiving TLE combination.
Conclusion: M. oleifera may be useful in improving blood triglyceride and LDL levels of patients receiving TLE combination.

Keywords


1.Romanelli F, Smith KM, Hoven AD (2004). "Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity". Current Pharmaceutical Design. 10 (21): 2643–8.
2.Murray SM, Down CM, Boulware DR, Stauffer WM, Cavert WP, Schacker TW, et al. (2010). "Reduction of immune activation with chloroquine therapy during chronic HIV infection". Journal of Virology. 84 (22): 12082–6.
3.Savarino A, Shytaj IL (2015). "Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS". Retrovirology. 12 (1): 51.
4.Lieberman-Blum SS, Fung HB, Bandres JC (2008). "Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection". Clinical Therapeutics. 30 (7): 1228–50.
5.Bai Y, Xue H, Wang K, Cai L, Qiu J, Bi S, et al. (2013). "Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket". Amino Acids. 44 (2): 701–13.
6.LaRosa JC, Grundy SM, Waters DD. (2005). “Intensive lipid lowering with atorvastatin in patients with stable coronary disease,” The New England Journal of Medicine, vol. 352, no. 14, pp. 1425–1435.
7.Meraiyebu, A., Ogunwole, E., and Izuchukwu, NS. (2014). Effects of Aqueous Extract of Moringa oleifera Seeds on Alloxan Induced Hyperglycemia. Basic Sciences of Medicine, 3(3): 37-42.
8.Moore RD, Chaisson RE (1999). Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS. 13 (14): 1933– 42.
9.Sabastine A. Z., Musa T. L., Joseph O. S., Builders M. and Joseph Opeyemi T. (2019). Histological study of effect of ethanol stem extracts of Homalium letestui in paracetamol induced injury in albino rat, using various staining techniques. American Journal of Biomedical Science & Research. 4(2). Page 82 – 89.
10.Joseph O.S., Builders M., Joseph O. T, Ariahu E. C., Zubairu S. A., Musa T. and Oyepata P.J. (2019). Toxicity study of ethanol leaf extract of ocimum canum on heart and lipid profile of wister rats. International Journal of Current Advanced Research. Volume 8. (Issue 05). Page 18800 – 18803.
11.Samson A. O., Joseph O. S., Samson O. A. and Emem R. A. (2019). Effect of Citrus Linton Juice and Tamoxifen on The oxidative activities of MCT-7 cell induced Bresat Cancer in Sprawgue Dawley Rats. Saudi Journal of Biomedical Research. Volume 8 (7). Page 76-92.
12.Perk G, De Backer H and Gohlke J. (2012). “European guidelines on cardiovascular disease prevention in clinical practice,” European Heart Journal, vol. 33, no. 13, pp. 1635–1701.
13.Joseph O. S, Builders M., Isinkaye D. R., Sebastine A. Z., Musa T., Oyepata J. P., Joseph O. T. and Wazis C. (2019). Sub-Acute Toxicity Study of Ethanol Leaf Extract of Terminalia chebula On Brain, Stomach and Spleen of Wister Rats. American Journal of Biomedical Science & Research. 3(3). Page 277-282.
14.Kansal SK, Kumari A. Potential of M. oleifera for the treatment of water and wastewater. Chem Rev. 2014;114:4993–5010.
15.Joseph O.S, Builders M., Joseph O, T. , Zubairu S. A., Musa T. And Oyepata P. J (2019). Sub-Acute Toxicity Study of Ethanol Leaf Extract of Ocimum Canum on Liver of Wister Rats. International Journal of Research and Scientific Innovation. Volume VI (V). Pp. 364-369.
16.Oyebadejo S. A, Joseph O. S, Adesite S. O and Omorilewa A.O. (2019). Effect of Citrus Limon Juice and Tamoxifen on the Tumour growth mass Indices, Cell Proliferation, Cell Viability and Cytogenetic (Mitotic Index) of Sprague Dawley Rats Induced MCF-7 Breast Cancer Cells. Saudi Journal of Biomedical Research. (4). Pg. 216 - 225.
17.Young TN, Arens FJ, Kennedy GE, Laurie JW, Rutherford GW (2007). Young T (ed.). "Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure". The Cochrane Database of Systematic Reviews (1):
18.Siegfried N, van der Merwe L, Brocklehurst P, Sint TT (2011). Siegfried N (ed.). "Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection". The Cochrane Database of Systematic Reviews (7): CD003510. doi:10.1002/14651858.CD003510.pub3. PMID 21735394.
19.WHO HIV and Infant Feeding Technical Consultation Held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV – Infections in Pregnant Women, Mothers and their Infants – Consensus statement" (PDF). October 25–27, 2006. Archived (PDF) from the original on April 9, 2008. Retrieved March 12, 2008.
20.Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS (2009). Horvath T (ed.). "Interventions for preventing late postnatal mother-to-child transmission of HIV". The Cochrane Database of Systematic Reviews (1): CD006734. doi:10.1002/14651858.CD006734.pub2. PMC 7389566. PMID 19160297.
21.WHO validates elimination of mother-to-child transmission of HIV and syphilis in Cuba". World Health Organization. June 30, 2015. Archived from the original on September 4, 2015. Retrieved August 30, 2015.
22.Reynell L, Trkola A (March 2012). "HIV vaccines: an attainable goal?". Swiss Medical Weekly. 142: w13535. doi:10.4414/smw.2012.13535. PMID 22389197.
23.U.S. Army Office of the Surgeon General (2011). "HIV Vaccine Trial in Thai Adults". ClinicalTrials.gov. Archived from the original on October 19, 2011. Retrieved June 28, 2011.
24.Modupe I. B., Oyepata S. J. and Akpobome R. V. (2019). Effect of Parkia biglobosa extract on open skin wound healing in dexamethasone - induced hyperglycaemia and histological assessment in rats. African Journal of Pharmacy and Pharmacology. Vol. 13(8), pp. 84-89.
25.Da Silva JPV, Serra TM, Gossmann M, et al. (2010). Moringa oleifera oil: studies of characterization and biodiesel production. Biomass Bioenergy;34:1527–1530. doi: 10.1016/j.biombioe.2010.04.002.
26.Builder M. I., Anzaku S. A. and Joseph S. O. (2019). Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine against malaria in northern Nigeria. International Journal of Recent Scientific Research Vol. 10 (05), pp. 32295-32299.
27.Doughari JH, Human SI, Bennade S, Ndakidemi PA (2009) Phytochemicals as chemotherapeutic agents and antioxidants: Possible solution to the control of antibiotic resistant verocytotoxin producing bacteria. J Med Plant Res 3: 839- 848. 2.
28.W.B Saunders, Edinburgh, Scotland. 3. Elujoba AA, Odeleye OM, Ogunyemi CM (2005) Traditional medicine development for medical and dental primary health care delivery system in Africa. Afr J Tradit Complement Altern Med 2: 46-61.
29.Edema AO (2012) Production of some common vegetables. Horticultural Research Institiute, Ibadan, Nigeria. Page36-48
30.Fasuyi AO (2006) Nutritional potentials of some tropical vegetable leaf meals, chemical characterization and functional properties. African J Biotechnol 5: 49- 53.
31.Akashi K,Traver D, Kondo M (1999) Lymphoid development from haematopoietic stem cells. Int J Haematol 69: 217-222.
32.Okochi YI, Akpotuzor J, Alli LA (2013) Comparism of an African herbal formula with commercially available haematinics. African J Biotechnol 2: 219-227.
33.Adusi-Poku Y, Sittie A, Mensah MLK, Sarpong K, Fleischer TC, et al. (2008) Effectiveness and safety assessment of mist tonica as herbal haematinic. Afr J Tradit Complement Altern Med 5: 115-119.
34.Adedapo AA, Mogbojuri OM, Emikpe BO (2009) Safety evaluations of the aqueous extract of the leaves of Moringa oleifera in rats. J Med Plants Res 3: 586-591.
35.Adias TC, Ajugwo AO, Erhabor T, Nyenke CU (2013) Effect of pumpkin extract (Telfairia occidentalis) on routine haematological parameters in acetoneinduced oxidative stress albino rats. Am J Food Sci Technol 1: 67-69.
36.Evans WC (2007) Pharmacognosy. (15th edtn), W.B Saunders, Edinburgh, Scotland.
37.Elujoba AA, Odeleye OM, Ogunyemi CM (2005) Traditional medicine development for medical and dental primary health care delivery system in Africa. Afr J Tradit Complement Altern Med 2: 46-61.
38.Edema AO (2012) Production of some common vegetables. Horticultural Research Institiute, Ibadan, Nigeria.
39.Akashi K,Traver D, Kondo M (1999) Lymphoid development from haematopoietic stem cells. Int J Haematol 69: 217-222.
40.Okochi YI, Akpotuzor J, Alli LA (2013) Comparism of an African herbal formula with commercially available haematinics. African J Biotechnol 2: 219-227.
41.Adusi-Poku Y, Sittie A, Mensah MLK, Sarpong K, Fleischer TC, et al. (2008) Effectiveness and safety assessment of mist tonica as herbal haematinic. Afr J Tradit Complement Altern Med 5: 115-119.
42.Adedapo AA, Mogbojuri OM, Emikpe BO (2009) Safety evaluations of the aqueous extract of the leaves of Moringa oleifera in rats. J Med Plants Res 3: 586-591.
43.Adias TC, Ajugwo AO, Erhabor T, Nyenke CU (2013) Effect of pumpkin extract (Telfairia occidentalis) on routine haematological parameters in acetoneinduced oxidative stress albino rats. Am J Food Sci Technol 1: 67-69.
44.Sharma VR, Paliwal R, Sharma S. Phytochemical analysis and evaluation of antioxidant activities of hydro-ethanolic extract of Moringa oleifera Lam. J Pharm Res. 2011;4(2):554–7.
45.Ndong M, Uehara M, Katsumata S, Suzuki K. Effects of oral administration of Moringa oleifera Lam on glucose tolerance in gotokakizaki and wistar rats. J of Clin Biochem and Nutri. 2007;40:229–33.
46.Gupta R, Mathur M, Bajaj VK, Katariya P, Yadav S, Kamal R, et al. Evaluation of antidiabetic and antioxidant activity of Moringa oleifera in experimental diabetes. J Diabetes. 2012;4(2):164–71.